To authorize the marketing of breast self-examination pads without restriction.

Mandates approval of the marketing of devices to aid in the self-examination of breasts without the Federal Food, Drug, and Cosmetic Act requirement that such devices be prescription-only or otherwise restricted in their availability to women.